Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Sonia Boyer-Suavet

Showing results (1-10 of 17) with videos related to

Pageof 2
Sort By:
Kidney International Reports|May 15, 2020
Complement Pathways in Membranous Nephropathy: Complex and MultifactorialVesna Brglez, Sonia Boyer-Suavet, Barbara Seitz-Polski
Kidney International Reports|April 29, 2021
Analysis and Management of Rituximab Resistance in PLA2R1-Associated Membranous NephropathyMaxime Teisseyre, Sonia Boyer-Suavet, Marion Crémoni, et al.
Kidney International Reports|July 31, 2024
Corrigendum to "Analysis and Management of Rituximab Resistance in PLA2R1-Associated Membranous Nephropathy" [<i>Kidney International Reports</i> Volume 6, Issue 4, April 2021, Pages 1183-1188]Maxime Teisseyre, Sonia Boyer-Suavet, Marion Crémoni, et al.
Frontiers in Medicine|September 9, 2020
Personalized Medicine for PLA2R1-Related Membranous Nephropathy: A Multicenter Randomized Control TrialVesna Brglez, Sonia Boyer-Suavet, Kévin Zorzi, et al.
Frontiers in Immunology|May 23, 2022
Advances in the Management of Primary Membranous Nephropathy and Rituximab-Refractory Membranous NephropathyMaxime Teisseyre, Marion Cremoni, Sonia Boyer-Suavet, et al.
Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association|April 1, 2019
Rituximab bioavailability in primary membranous nephropathySonia Boyer-Suavet, Marine Andreani, Marion Cremoni, et al.
Frontiers in Immunology|November 1, 2021
Rituximab Immunomonitoring Predicts Remission in Membranous NephropathyMaxime Teisseyre, Marion Cremoni, Sonia Boyer-Suavet, et al.
Clinical Journal of the American Society of Nephrology : CJASN|March 21, 2023
Risk Factors Associated with the Occurrence of Anti-rituximab Antibodies in Membranous NephropathyMaxime Teisseyre, Vesna Brglez, Marion Cremoni, et al.
Frontiers in Immunology|January 31, 2020
Neutralizing Anti-Rituximab Antibodies and Relapse in Membranous Nephropathy Treated With RituximabSonia Boyer-Suavet, Marine Andreani, Maël Lateb, et al.
Frontiers in Physiology|March 26, 2021
Proteinuria as a Biomarker for COVID-19 SeverityHajar Ouahmi, Johan Courjon, Lucas Morand, et al.
Pageof 2

Showing results (1-10 of 17) with videos related to

Sort By:
Pageof 2
Kidney International Reports|May 15, 2020
Complement Pathways in Membranous Nephropathy: Complex and MultifactorialVesna Brglez, Sonia Boyer-Suavet, Barbara Seitz-Polski
Kidney International Reports|April 29, 2021
Analysis and Management of Rituximab Resistance in PLA2R1-Associated Membranous NephropathyMaxime Teisseyre, Sonia Boyer-Suavet, Marion Crémoni, et al.
Kidney International Reports|July 31, 2024
Corrigendum to "Analysis and Management of Rituximab Resistance in PLA2R1-Associated Membranous Nephropathy" [<i>Kidney International Reports</i> Volume 6, Issue 4, April 2021, Pages 1183-1188]Maxime Teisseyre, Sonia Boyer-Suavet, Marion Crémoni, et al.
Frontiers in Medicine|September 9, 2020
Personalized Medicine for PLA2R1-Related Membranous Nephropathy: A Multicenter Randomized Control TrialVesna Brglez, Sonia Boyer-Suavet, Kévin Zorzi, et al.
Frontiers in Immunology|May 23, 2022
Advances in the Management of Primary Membranous Nephropathy and Rituximab-Refractory Membranous NephropathyMaxime Teisseyre, Marion Cremoni, Sonia Boyer-Suavet, et al.
Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association|April 1, 2019
Rituximab bioavailability in primary membranous nephropathySonia Boyer-Suavet, Marine Andreani, Marion Cremoni, et al.
Frontiers in Immunology|November 1, 2021
Rituximab Immunomonitoring Predicts Remission in Membranous NephropathyMaxime Teisseyre, Marion Cremoni, Sonia Boyer-Suavet, et al.
Clinical Journal of the American Society of Nephrology : CJASN|March 21, 2023
Risk Factors Associated with the Occurrence of Anti-rituximab Antibodies in Membranous NephropathyMaxime Teisseyre, Vesna Brglez, Marion Cremoni, et al.
Frontiers in Immunology|January 31, 2020
Neutralizing Anti-Rituximab Antibodies and Relapse in Membranous Nephropathy Treated With RituximabSonia Boyer-Suavet, Marine Andreani, Maël Lateb, et al.
Frontiers in Physiology|March 26, 2021
Proteinuria as a Biomarker for COVID-19 SeverityHajar Ouahmi, Johan Courjon, Lucas Morand, et al.
Pageof 2